MTCP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.270140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.332400E-01
Normal-vs-Stage2
2.150400E-02
Normal-vs-Stage3
1.817720E-02
Normal-vs-Stage4
1.175160E-01
Stage1-vs-Stage2
2.845000E-01
Stage1-vs-Stage3
1.292240E-02
Stage1-vs-Stage4
2.892600E-01
Stage2-vs-Stage3
5.668400E-02
Stage2-vs-Stage4
7.542800E-01
Stage3-vs-Stage4
1.214150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.010350E-02
Normal-vs-AfricanAmerican
3.203000E-01
Normal-vs-Asian
8.088300E-02
Caucasian-vs-AfricanAmerican
8.445400E-01
Caucasian-vs-Asian
5.713800E-01
AfricanAmerican-vs-Asian
9.852400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.177800E-03
Normal-vs-Female
2.820300E-02
Male-vs-Female
4.596200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.505400E-01
Normal-vs-Age(41-60Yrs)
6.260400E-02
Normal-vs-Age(61-80Yrs)
6.678700E-03
Normal-vs-Age(81-100Yrs)
2.659400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.725400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.849900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.309600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.662600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.774100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.720400E-03
Normal-vs-Daily Drinker
1.696220E-01
Normal-vs-Weekly Drinker
2.781800E-02
Normal-vs-Occasional Drinker
6.644100E-02
Normal-vs-Social Drinker
1.007810E-01
Non Drinker-vs-Daily Drinker
4.000000E-01
Non Drinker-vs-Weekly Drinker
6.937400E-01
Non Drinker-vs-Occasional Drinker
5.183000E-01
Non Drinker-vs-Social Drinker
1.561990E-01
Daily Drinker-vs-Weekly Drinker
6.292200E-01
Daily Drinker-vs-Occasional Drinker
7.913600E-01
Daily Drinker-vs-Social Drinker
7.885200E-01
Weekly Drinker-vs-Occasional Drinker
8.311800E-01
Weekly Drinker-vs-Social Drinker
3.827600E-01
Occasional Drinker-vs-Social Drinker
5.399800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.506200E-01
Normal-vs-Grade 2
9.732000E-02
Normal-vs-Grade 3
1.254840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.870600E-01
Grade 1-vs-Grade 3
5.149200E-01
Grade 1-vs-Grade 4
2.506200E-01
Grade 2-vs-Grade 3
6.213800E-01
Grade 2-vs-Grade 4
9.732000E-02
Grade 3-vs-Grade 4
1.254840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.544900E-03
Normal-vs-NonDiabetic
2.306300E-02
Diabetic-vs-NonDiabetic
1.124000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.881400E-01
Normal-vs-NoPancreatitis
4.215300E-03
Pancreatitis-vs-NoPancreatitis
6.002000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.278700E-03
Normal-vs-N1
1.752390E-02
N0-vs-N1
6.685800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.417420E-01
Normal-vs-TP53-NonMutant
6.371800E-02
TP53-Mutant-vs-TP53-NonMutant
3.194600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
